Knee OsteoArthritis Long-term Assessment
NCT: NCT06839222 · WITHDRAWN
Brief Summary
The goal of this clinical study is to learn if Hydrogel OA 2% injection is safe and whether it works to improve symptoms of diagnosed knee osteoarthritis in adults when compared to Hyaluronic Acid (Durolane), a treatment that is currently often used for treatment of knee osteoarthritis. The main question it aims to answer is: \- How many study participants will experience side effects related to Hydrogel OA 2% during the study when compared to Hyaluronic Acid (Durolane)? All study participants will receive either one Hydrogel OA 2% or Hyaluronic Acid (Durolane) injection in their knee during the clinical study. Study participants will not know which treatment they have received. Study participants will also receive a call from the researchers and visit the clinic three times to report whether they have experienced any side effects, and complete a questionnaire that will ask questions on whether their symptoms have improved since they received an injection.
Frequently Asked Questions
What is Knee OsteoArthritis Long-term Assessment?
Knee OsteoArthritis Long-term Assessment is a clinical trial registered under NCT06839222. Current status: WITHDRAWN.
What is the status of NCT06839222?
The current status of NCT06839222 (Knee OsteoArthritis Long-term Assessment) is: WITHDRAWN.
When did Knee OsteoArthritis Long-term Assessment start?
Knee OsteoArthritis Long-term Assessment started on 2025-05.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.